Computational Analyses of Docosahexaenoic Acid (DHA, C22:6, n-3) with Alzheimer’s Disease-Causing Amyloid Peptide A<i>β</i><sub>1-42</sub> Reassures Its Therapeutic Utility

ISSN Print: 2169-2459
ISSN Online: 2169-2467
www.scirp.net/journal/aad
E-mail: [email protected]

Citations

"Computational Analyses of Docosahexaenoic Acid (DHA, C22:6, n-3) with Alzheimer’s Disease-Causing Amyloid Peptide Aβ_1-42 Reassures Its Therapeutic Utility"
written by Michio Hashimoto, Shahdat Hossain, Kentaro Matsuzaki, Abdullah Al Mamun, Hiroyuki Arai, Osamu Shido,
published by Advances in Alzheimer's Disease, Vol.5 No.2, 2016

has been cited by the following article(s):

[1]	The Multifunctional Therapeutic Approach to Treatment of Alzheimer's Disease: Molecular Bases, Pharmacology and Perspectives in Medicinal Chemistry
	Am J Biomed Sci & Res, 2019

[2]	Dimer-monomer equilibrium of human HSP27 is influenced by the in-cell macromolecular crowding environment and is controlled by fatty acids and heat
	Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2018

[3]	Combined in silico approaches for the identification of novel inhibitors of human islet amyloid polypeptide (hIAPP) fibrillation
	Journal of Molecular Graphics and Modelling, 2017

Top

[1]	A full-active phosphorus dendron-based nanomedicine alleviates ischemic stroke through multi-target immunomodulation and neuroprotection Bioactive Materials, 2026 DOI:10.1016/j.bioactmat.2026.04.007

[2]	Combined in silico approaches for the identification of novel inhibitors of human islet amyloid polypeptide (hIAPP) fibrillation Journal of Molecular Graphics and Modelling, 2017 DOI:10.1016/j.jmgm.2017.09.004